2013 Fiscal Year Final Research Report
The elucidation of the mechanism of growth suppression of melanoma by kinase inhibitor
Project/Area Number |
23591614
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Dermatology
|
Research Institution | University of Yamanashi |
Principal Investigator |
|
Project Period (FY) |
2011 – 2013
|
Keywords | キナーゼ阻害薬 / シグナル伝達系 / 悪性黒色腫 |
Research Abstract |
Wnt sinaling pathway has a crucial role in tumorgenesis. Some report have demonstrated that this signaling pathway was activated in melanoma. In this study, we evaluated whether celecoxib, a NSAIDs inhibited Wnt signaling pathway or not. If celecoxib suppressed Wnt signaling, this drug can be used as a molecular targeting drug. The expression of beta-catenin in melanoma samples was assessed by immunohistochemistry. Some melanoma samples expressed beta-catenin. Next, celecoxib was administrated in cell culture medium of melanoma cells. This experiment revealed that celecoxib inhibited the growth of melanoma cells. The relationship between the amount of beta-catenin in melanoma cells and the extent of growth suppression of melanoma cells was investigated, suggesting correlation of Wnt signal activation and the effect of growth inhibition of melanoma cells.
|
-
[Journal Article] Case of primary cutaneous peripheral T-cell lymphoma, not otherwise specified, with characteristics of follicular helper T cells2014
Author(s)
Takaki M, Inozume T, Matsuzawa T, Ando N, Yamaguchi M, Harada K, Kawamura T, Shibagaki N, Shimada S
-
Journal Title
DOI
Peer Reviewed
-
-
-
-
-
[Journal Article] Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level2012
Author(s)
Sakaizawa K, Goto Y, Kiniwa Y, Uchiyama A, Harada K, Shimada S, Saida T, Ferrone S, Takata M, Uhara H, Okuyama R
-
Journal Title
Br J Cancer
Volume: 106(5)(Epub 2012 Jan 26. PubMed PMID:22281663; PubMed Central PMCID:PMC3305957)
Pages: 939-46
DOI
Peer Reviewed
-
-
-